<
AI
Automation
Science
Innovation
Open Source
Blockchain
Social Media
Startups
Culture
Cloud
>

Destination
UK startup turns planetary biodiversity into AI-generated drug candidates

UK company Basecamp Research has developed AI models together with researchers from Nvidia and Microsoft that generate potential new therapies against cancer and multidrug-resistant bacteria from a database of over one million species.<br /> The article UK startup turns planetary biodiversity into AI-generated drug candidates appeared first on The Decoder. [...]

Discover Copy
Rating

Innovation

Pricing

Technology

Usability

We have discovered similar tools to what you are looking for. Check out our suggestions for similar AI tools.

Destination
Trump's defunding of NASA would be catastrophic

"This is probably the most uncertain future NASA has faced, maybe since the end of Apollo," Casey Dreier tells me over the phone. Dreier is the chief of space policy at The Planetary Society [...]

Match Score: 54.84

Destination
NASA finally has a leader, but its future is no more certain

After a rudderless year and an exodus of around 4,000 employees due to Trump administration cuts, NASA got what may be its first piece of good news recently. On December 17, the Senate confirmed billi [...]

Match Score: 36.56

venturebeat
Stanford researchers will discuss their agentic 'scientists' that are on course to reshape drug discovery at VB Transform 2026

Drug discovery is notoriously inefficient. Pharmaceutical projects span years, moving from one specialized human team to the next through disconnected workflows that result in knowledge loss during ea [...]

Match Score: 36.21

Destination
8 key drug patents expiring soon — and what it means for the market

Nothing drives down a drug’s price like competition. According the U.S. Food and Drug Administration (FDA), a drug’s wholesale price drops by an average of 39% after just one generic competitor en [...]

Match Score: 34.72

Destination
Pfizer, drug companies make 'no commitments' to White House about lowering drug prices

Cheaper pharmaceuticals won’t be on shelves any time soon, says the CEO of Pfizer. That’s despite an executive order signed last month declaring a war on drug prices, which at one point President [...]

Match Score: 34.49

Destination
Google's AI drug discovery spinoff Isomorphic Labs claims major leap beyond AlphaFold 3

Isomorphic Labs, Google DeepMind's AI medicine startup, has unveiled a new system called "Isomorphic Labs Drug Design Engine" (IsoDDE) that it says doubles AlphaFold 3's accuracy f [...]

Match Score: 31.90

Destination
Alphabet's Isomorphic Labs raises $2.1 billion to scale AI drug discovery toward clinical trials

Isomorphic Labs, the AI drug research company led by DeepMind co-founder Demis Hassabis, has closed a $2.1 billion Series B round led by Thrive Capital. The funding will go toward expanding its in-hou [...]

Match Score: 31.21

thenextweb
Will AI revolutionise drug development? Researchers say it depends on how it’s used

The potential of using artificial intelligence in drug discovery and development has sparked both excitement and skepticism among scientists, investors and the general public. “Artificial intelligen [...]

Match Score: 30.18

venturebeat
New Alibaba AI framework skips loading every tool, cutting agent token use 99%

As enterprise AI systems scale to handle complex workflows, practitioners face the challenge of routing subtasks to the right tools and skills. Agents can have hundreds of tools and skills and get con [...]

Match Score: 29.76